UOC
UBS O'Connor Portfolio holdings
AUM
$1.93B
1-Year Return
38.75%
This Quarter Return
+7.72%
1 Year Return
+38.75%
3 Year Return
+182.42%
5 Year Return
+480.25%
10 Year Return
+1,573.29%
AUM
$4.73B
AUM Growth
+$538M
(+13%)
Cap. Flow
+$103M
Cap. Flow
% of AUM
2.17%
Top 10 Holdings %
Top 10 Hldgs %
48.18%
Holding
712
New
102
Increased
142
Reduced
245
Closed
144
Top Buys
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$245M |
| 2 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$230M |
| 3 |
PDCE
PDC Energy, Inc.
PDCE
|
+$221M |
| 4 |
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
|
+$141M |
| 5 |
LSI
Life Storage, Inc.
LSI
|
+$87.5M |
Top Sells
| 1 |
First Horizon
FHN
|
+$179M |
| 2 |
AQUA
Evoqua Water Technologies Corp. Common Stock
AQUA
|
+$146M |
| 3 |
PRVB
Provention Bio, Inc. Common Stock
PRVB
|
+$70.5M |
| 4 |
Tower Semiconductor
TSEM
|
+$46.1M |
| 5 |
XM
Qualtrics International Inc. Class A Common Stock
XM
|
+$45.3M |
Sector Composition
| 1 | Healthcare | 32.5% |
| 2 | Technology | 15.54% |
| 3 | Financials | 12.09% |
| 4 | Real Estate | 8.52% |
| 5 | Materials | 5.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AKTS
401
DELISTED
AKOUSTIS TECHNOLOGIES, INC.
AKTS
| $636K | 0.01% |
200,000
+100,000
| +100% | +$318K |
|
402
Mirum Pharmaceuticals
MIRM
$3.89B
| $621K | 0.01% |
+24,000
| New | +$621K |
|
403
Chart Industries
GTLS
$8.98B
| $616K | 0.01% |
+3,856
| New | +$616K |
|
404
WIX.com
WIX
$9.3B
| $587K | 0.01% |
+7,500
| New | +$587K |
|
|
KLRS
405
Kalaris Therapeutics, Inc. Common Stock
KLRS
$86.8M
| $578K | 0.01% |
+7,391
| New | +$578K |
|
406
TripAdvisor
TRIP
$2.02B
| $577K | 0.01% |
35,000
+10,000
| +40% | +$165K |
|
407
LGI Homes
LGIH
$1.53B
| $577K | 0.01% |
+4,275
| New | +$577K |
|
408
enVVeno Medical
NVNO
$13.8M
| $575K | 0.01% |
186,814
+9,204
| +5% | +$28.3K |
|
409
KBR
KBR
$6.35B
| $572K | 0.01% |
+8,792
| New | +$572K |
|
410
Healthpeak Properties
DOC
$12.7B
| $547K | 0.01% |
+27,200
| New | +$547K |
|
411
Elanco Animal Health
ELAN
$9.46B
| $545K | 0.01% |
54,176
+12,176
| +29% | +$122K |
|
412
Aura Biosciences
AURA
$402M
| $543K | 0.01% |
+44,000
| New | +$543K |
|
|
SLN
413
Silence Therapeutics
SLN
$254M
| $541K | 0.01% |
98,326
+2,943
| +3% | +$16.2K |
|
|
LCA
414
DELISTED
Landcadia Holdings IV, Inc. Class A Common Stock
LCA
| $515K | 0.01% |
50,644
-1,141
| -2% | -$11.6K |
|
|
RETA
415
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $510K | 0.01% |
5,000
-250
| -5% | -$25.5K |
|
416
WESCO International
WCC
$10.3B
| $507K | 0.01% |
+2,830
| New | +$507K |
|
417
Adobe
ADBE
$150B
| $505K | 0.01% |
1,033
-8,967
| -90% | -$4.38M |
|
418
CareTrust REIT
CTRE
$7.68B
| $502K | 0.01% |
+25,270
| New | +$502K |
|
419
Asana
ASAN
$3.29B
| $474K | 0.01% |
21,510
-203,490
| -90% | -$4.48M |
|
420
Penumbra
PEN
$11.1B
| $471K | 0.01% |
1,369
-1,073
| -44% | -$369K |
|
|
UBX
421
DELISTED
Unity Biotechnology
UBX
| $457K | 0.01% |
179,080
-33,960
| -16% | -$86.6K |
|
422
CytomX Therapeutics
CTMX
$360M
| $447K | 0.01% |
259,965
+12,808
| +5% | +$22K |
|
423
Leap Therapeutics
LPTX
$11.8M
| $436K | 0.01% |
139,434
+34,565
| +33% | +$108K |
|
424
Ovid Therapeutics
OVID
$88.2M
| $426K | 0.01% |
+130,000
| New | +$426K |
|
|
SPLK
425
DELISTED
Splunk Inc
SPLK
| $424K | 0.01% |
+4,000
| New | +$424K |
|